| meta-analysis | Q815382 |
| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1136/THORAXJNL-2016-208704 |
| P698 | PubMed publication ID | 27388487 |
| P50 | author | Jos Kleijnen | Q28037365 |
| Gerta Rücker | Q28323616 | ||
| Klaus Linde | Q42305790 | ||
| P2093 | author name string | Stefan Karrasch | |
| Antonius Schneider | |||
| Rudolf A Jörres | |||
| Marlies Karsch-Völk | |||
| Harriet Sommer | |||
| P2860 | cites work | Epithelial inducible nitric oxide synthase activity is the major determinant of nitric oxide concentration in exhaled breath | Q24678621 |
| Measurement of exhaled nitric oxide concentration in asthma: a systematic review and economic evaluation of NIOX MINO, NIOX VERO and NObreath | Q26781270 | ||
| Quantifying heterogeneity in a meta-analysis | Q27860672 | ||
| QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies | Q27861031 | ||
| Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews | Q29619492 | ||
| Diagnostic accuracy of spirometry in primary care | Q33480686 | ||
| Lebrikizumab treatment in adults with asthma | Q34205683 | ||
| ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. | Q34409752 | ||
| Clinical usefulness of fractional exhaled nitric oxide for diagnosing prolonged cough | Q34794003 | ||
| Multiple roles of nitric oxide in the airways. | Q35055532 | ||
| An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications | Q35534747 | ||
| Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma | Q35563919 | ||
| Influence of the practice setting on diagnostic prediction rules using FENO measurement in combination with clinical signs and symptoms of asthma | Q36329198 | ||
| Use of methodological search filters to identify diagnostic accuracy studies can lead to the omission of relevant studies. | Q36400900 | ||
| Comparative accuracy: assessing new tests against existing diagnostic pathways | Q36468809 | ||
| Diagnosing asthma in general practice with portable exhaled nitric oxide measurement--results of a prospective diagnostic study: FENO < or = 16 ppb better than FENO < or =12 ppb to rule out mild and moderate to severe asthma [added]. | Q37140439 | ||
| Mepolizumab and exacerbations of refractory eosinophilic asthma | Q37711391 | ||
| Current evidence and future research needs for FeNO measurement in respiratory diseases | Q38196605 | ||
| Usefulness of exhaled nitric oxide for diagnosing asthma | Q42934151 | ||
| Diagnostic value of peak flow variability in patients with suspected diagnosis of bronchial asthma in general practice | Q43267296 | ||
| Exhaled nitric oxide in evaluation of young adults with chronic cough | Q43281496 | ||
| Inflammatory subtypes in asthma are related to airway hyperresponsiveness to mannitol and exhaled NO. | Q43297954 | ||
| Differences in local and systemic inflammatory markers in patients with obstructive airways disease | Q43452631 | ||
| A comparison of the validity of different diagnostic tests in adults with asthma. | Q43955597 | ||
| Exhaled nitric oxide as a predictor of exercise-induced bronchoconstriction | Q44542289 | ||
| Exhaled nitric oxide: a predictor of steroid response | Q46496987 | ||
| Exhaled nitric oxide as screening tool in subjects with suspected asthma without reversibility. | Q46798080 | ||
| The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. | Q47372679 | ||
| The use of exhaled nitric oxide in the diagnosis of asthma in school children | Q48402544 | ||
| Portable exhaled nitric oxide as a screening tool for asthma in young adults during pollen season. | Q50881284 | ||
| Relation of bronchial and alveolar nitric oxide to exercise-induced bronchoconstriction in atopic children and adolescents. | Q50987555 | ||
| Exhaled nitric oxide and screening for occupational asthma in two at-risk sectors: bakery and hairdressing. | Q51081104 | ||
| Predicting steroid responsiveness in patients with asthma using exhaled breath profiling. | Q51148703 | ||
| The utility of exhaled nitric oxide in patients with suspected asthma. | Q51545293 | ||
| Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. | Q51641626 | ||
| A unification of models for meta-analysis of diagnostic accuracy studies | Q56529110 | ||
| Exhaled nitric oxide and influencing factors in a random population sample | Q57414521 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | asthma | Q35869 |
| P304 | page(s) | 109-116 | |
| P577 | publication date | 2016-07-07 | |
| P1433 | published in | Thorax | Q7796158 |
| P1476 | title | Accuracy of FENO for diagnosing asthma: a systematic review | |
| P478 | volume | 72 |
| Q47596939 | Advances in environmental and occupational disorders in 2016. |
| Q97886201 | Are type-2 biomarkers of any help in asthma diagnosis? |
| Q48297211 | Assessment of eosinophilic airway inflammation as a contribution to the diagnosis of occupational asthma. |
| Q55251217 | Elevated Serum Interleukin-8 Level as a Preferable Biomarker for Identifying Uncontrolled Asthma and Glucocorticosteroid Responsiveness. |
| Q58797586 | Exhaled biomarkers in childhood asthma: old and new approaches |
| Q91742924 | Fractional Exhaled Nitric Oxide (FENO) in the management of asthma: a position paper of the Italian Respiratory Society (SIP/IRS) and Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC) |
| Q92652387 | Fractional Exhaled Nitric Oxide Testing: Diagnostic Utility in Asthma, Chronic Obstructive Pulmonary Disease, or Asthma-chronic Obstructive Pulmonary Disease Overlap Syndrome |
| Q64258780 | Fractional exhaled nitric oxide in preterm-born subjects: A systematic review and meta-analysis |
| Q57585034 | Psoriasis and Respiratory Comorbidities: The Added Value of Fraction of Exhaled Nitric Oxide as a New Method to Detect, Evaluate, and Monitor Psoriatic Systemic Involvement and Therapeutic Efficacy |
| Q47113948 | Pulmonary function, exhaled nitric oxide and symptoms in asthma patients with obesity: a cross-sectional study |
| Q91640456 | Relationship between Particulate Matter (PM10) and Airway Inflammation Measured with Exhaled Nitric Oxide Test in Seoul, Korea |
| Q30360362 | Targeting patients with asthma for omalizumab therapy: choosing the right patient to get the best value for money. |
| Q53561642 | [Clinical significance of peripheral blood neutrophil-lymphocyte ratio and platelet- lymphocyte ratio in patients with asthma]. |
Search more.